
Background The α‐synuclein origin model proposes brain‐first and body‐first Parkinson's disease (PD) subtypes, with speech potentially revealing their distinct neurodegenerative patterns. Objective We aimed to analyze the possible speech and language differences between untreated PD patients with premotor (putative body‐first) and without (putative brain‐first) rapid eye movement sleep behavior disorder. Methods Speech samples of reading passages and monologues were automatically analyzed using acoustic and linguistic features. Results We enrolled 23 body‐first and 35 brain‐first de novo PD patients compared with 35 healthy controls. Brain‐first patients showed greater speech impairment severity compared with body‐first patients ( P = 0.002) and controls ( P < 0.001), whereas body‐first patients showed greater language impairment severity compared with brain‐first patients ( P < 0.001) and controls ( P < 0.001). Conclusions Putative brain‐first subtype had more motor speech abnormalities whereas body‐first subtype manifested greater language impairment. Thes finding is consistent with motor‐dominant nigrostriatal involvement in brain‐first and broader non‐motor/cognitive involvement in body‐first PD. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Spinocerebellar ataxia type 2 (SCA2) is one of the most extensively investigated hereditary ataxias worldwide. Although the first clinical description of the disorder was reported in India in 1971 by Wadia and Swami, the province of Holguín, Cuba subsequently became recognized as a major geographical focus of SCA2, with a particularly high concentration of affected families and individuals, where it became internationally recognized as Cuban ataxia. Since the late 1970s, Cuban investigators have played a pivotal role in the clinical, epidemiological, neuropathological, and genetic characterization of the disorder. This article presents a historical review of the scientific development of Cuban ataxia based on a comprehensive bibliographic and documentary analysis, complemented by interviews with key neurologists involved in its early investigation. Particular emphasis is placed on the pioneering contributions of José Rafael Estrada González, Lionel Valles Calaña, Guillermo Orozco Díaz, and Luis Velázquez Pérez, whose work established the foundations for the current understanding of SCA2. Their investigations culminated in the identification of one of the world's largest SCA2 clusters and substantially advanced knowledge of the disease's clinical spectrum, epidemiology, and molecular genetics. The Cuban experience illustrates how sustained clinical observation, multidisciplinary collaboration, and international partnerships transformed a regional neurological disorder into one of the best‐characterized hereditary ataxias worldwide. © 2026 International Parkinson and Movement Disorder Society.
Abstract Background Multiple system atrophy (MSA) is primarily characterized by subcortical neurodegeneration. However, neuropathological evidence indicates that cortical neurodegeneration is also part of the disease. Conventional neuroimaging measures, such as cortical thickness (CTh), have been used to assess cortical macrostructural alterations, but findings remain limited and inconclusive. In this context, cortical mean diffusivity (cMD) has emerged as a promising marker of microstructural integrity, capturing alterations beyond macrostructural changes in other neurodegenerative disorders. However, its role in MSA remains largely unexplored. Objectives The objective of the study was to characterize cortical macro‐ and microstructural alterations in MSA and assess associations with clinical severity and cognitive performance. Methods T1‐weighted and diffusion magnetic resonance imaging (MRI), clinical, and neuropsychological assessments were obtained in 29 patients with MSA and 35 age‐ and sex‐matched controls (HCs). Cortical macro‐ and microstructural alterations were evaluated using CTh and cMD, respectively. Group comparisons and correlations between MRI‐derived cortical measures and clinical, cognitive, and neurodegeneration biomarkers were conducted ( P < 0.05, false discovery rate [FDR]‐corrected). Results Patients with MSA exhibited widespread increases in cMD, predominantly affecting the frontal and temporal cortices. This pattern partially overlapped with cortical thinning, although cMD alterations extended to rostral‐lateral, rostral‐medial, and inferior‐medial regions. In MSA, increased cMD was associated with global cognitive impairment, whereas cortical thinning correlated with disease severity. Conclusions MSA involves concurrent macro‐ and microstructural cortical alterations, with microstructural changes potentially preceding overt atrophy and indicating early pathology. Distinct cMD and CTh patterns suggest partially independent processes, whereas differential clinical associations highlight their complementarity. Together, these markers improve the characterization of cortical degeneration and disease heterogeneity. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.